NFE2, nuclear factor, erythroid 2, 4778

N. diseases: 57; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023241
Disease: Legionnaires' Disease
Legionnaires' Disease
0.010 Biomarker disease BEFREE Legionnaires' Disease Mortality in Guinea Pigs Involves the p45 Mobile Genomic Element. 31268152 2019
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE A decrease in the ECR pressure pain thresholds was correlated (P < .027) with an increase in the P45 amplitude at a centroparietal recording site. 29803671 2018
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. 24026423 2014
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. 24026423 2014
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASCAT A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. 19820697 2009
Platelet mean volume determination (procedure)
0.100 GeneticVariation phenotype GWASDB A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. 19820697 2009
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential
0.030 Biomarker disease BEFREE A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis? 23932394 2014
CUI: C0001815
Disease: Primary Myelofibrosis
Primary Myelofibrosis
0.010 Biomarker disease BEFREE A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis? 23932394 2014
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis
0.010 Biomarker disease BEFREE A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis? 23932394 2014
CUI: C0021841
Disease: Intestinal Neoplasms
Intestinal Neoplasms
0.010 AlteredExpression group BEFREE Activation of NF-E2 p45-related factor-2 transcription and inhibition of intestinal tumor development by AHCC, a standardized extract of cultured <i>Lentinula edodes</i> mycelia. 31777421 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.010 Biomarker disease BEFREE Additionally, beta power enhancement appears to contribute to the P45 component depression in 3.0 Hz-RPM. 30177877 2018
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE Additionally, beta power enhancement appears to contribute to the P45 component depression in 3.0 Hz-RPM. 30177877 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.010 Biomarker phenotype BEFREE Additionally, beta power enhancement appears to contribute to the P45 component depression in 3.0 Hz-RPM. 30177877 2018
CUI: C0023465
Disease: Acute monocytic leukemia
Acute monocytic leukemia
0.010 AlteredExpression disease BEFREE Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. 30755419 2019
CUI: C0032463
Disease: Polycythemia Vera
Polycythemia Vera
0.070 GeneticVariation disease BEFREE Although NF-E2 levels correlate with JAK2(V671F) allele burden in some PV cohorts, the molecular mechanism causing aberrant NF-E2 expression has not been described. 20339092 2010
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential
0.030 Biomarker disease BEFREE Although real-time RT-PCR showed that both a and f NF-E2 isoforms were significantly reduced with respect to the normal counterpart both in ET megakaryocytes and in cell lines (P < or = 0.01), western blotting revealed decreased NF-E2 protein expression only in the latter. 12200693 2002
CUI: C0027022
Disease: Myeloproliferative disease
Myeloproliferative disease
0.060 AlteredExpression group BEFREE AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2. 20339092 2010
CUI: C0271979
Disease: Thalassemia Intermedia
Thalassemia Intermedia
0.010 Biomarker disease BEFREE Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations. 21232998 2011
CUI: C0042900
Disease: Vitiligo
Vitiligo
0.020 AlteredExpression disease BEFREE Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway. 30342186 2018
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
0.020 AlteredExpression disease BEFREE Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway. 30342186 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 AlteredExpression phenotype BEFREE Ectopic expression of reconstituted p45 MET in epithelial cell lines favored cell scattering and invasion indicating active role of this fragment in HGF/SF induced responses. 28061464 2017
CUI: C0027022
Disease: Myeloproliferative disease
Myeloproliferative disease
0.060 AlteredExpression group BEFREE Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. 29519804 2018
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion
0.010 Biomarker disease BEFREE Furthermore, our results demonstrated that luteoloside significantly suppressed the activation of nuclear factor-kappa B (NF-κB) signaling, upregulated the protein expression of peroxisome proliferator activated receptor gamma (PPARγ) and increased NF-E2-related factor (Nrf2) nuclear accumulation in MCAO rats. 30502652 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 AlteredExpression disease BEFREE Hepatic NFE2 overexpression upregulated miR-423-5p to repress the FAM3A-ATP-Akt pathway, promoting gluconeogenesis and lipid deposition and causing hyperglycemia in normal mice. 28411267 2017
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential
0.030 GeneticVariation disease BEFREE Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation. 20339092 2010